pBMN(CMV-copGFP-Puro-SMAR) Citations (2)

Originally described in: Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer.
Jin C, Fotaki G, Ramachandran M, Nilsson B, Essand M, Yu D EMBO Mol Med. 2016 May 6. pii: e201505869. doi: 10.15252/emmm.201505869. PubMed Journal

Articles Citing pBMN(CMV-copGFP-Puro-SMAR)

Articles
EPISOMAL VECTORS FOR STABLE PRODUCTION OF RECOMBINANT PROTEINS AND ENGINEERED ANTIBODIES. Fallahee I, Hawiger D. bioRxiv. 2024 Jan 4:2024.01.03.574076. doi: 10.1101/2024.01.03.574076. Preprint. PubMed
Episomal Vectors for Stable Production of Recombinant Proteins and Engineered Antibodies. Fallahee I, Hawiger D. Antibodies (Basel). 2024 Mar 11;13(1):18. doi: 10.3390/antib13010018. PubMed Associated Plasmids pCMV-protein1-IRES-protein2-IRESatt-EGFP-2A-PuroR-SMAR-g5 pCMV-protein1-IRES-protein2-IRESatt-EGFP-2A-nTermPuroR-nTermIntein pCMV-protein1-IRES-protein2-IRESatt-cTermIntein-cTermPuroR

If you have published an article using this material, please email us at [email protected] to have your article added to this page.